Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.1M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$34.8M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$33.2M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$30.7M |
| 5 |
DaVita
DVA
|
+$30.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$170M |
| 2 |
STJ
St Jude Medical
STJ
|
+$40.7M |
| 3 |
Danaher
DHR
|
+$37.7M |
| 4 |
Mettler-Toledo International
MTD
|
+$34M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$32.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.81% |
| 2 | Consumer Discretionary | 10.65% |
| 3 | Industrials | 10.41% |
| 4 | Healthcare | 10.37% |
| 5 | Technology | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Tyson Foods
TSN
$20.6B
| $2.73M | 0.08% |
44,155
+30,855
| +232% | +$1.94M |
|
|
LSXMK
152
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $2.67M | 0.08% |
90,228
-12,354
| -12% | -$349K |
|
153
Hyatt Hotels
H
$17B
| $2.63M | 0.08% |
48,712
+2,411
| +5% | +$130K |
|
|
PLYA
154
DELISTED
Playa Hotels & Resorts
PLYA
| $2.63M | 0.08% |
+250,000
| New | +$2.58M |
|
155
Commercial Metals
CMC
$7.34B
| $2.59M | 0.08% |
135,300
+120,100
| +790% | +$2.46M |
|
156
LyondellBasell Industries
LYB
$21.8B
| $2.59M | 0.08% |
28,366
+23,366
| +467% | +$2.13M |
|
157
Air Products & Chemicals
APD
$67.9B
| $2.52M | 0.08% |
18,634
+7,387
| +66% | +$1.04M |
|
158
Service Corp International
SCI
$11.4B
| $2.49M | 0.08% |
80,733
-8,246
| -9% | -$248K |
|
159
Merit Medical Systems
MMSI
$5.42B
| $2.48M | 0.08% |
+85,779
| New | +$2.4M |
|
|
LVNTA
160
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $2.46M | 0.08% |
55,215
| – | – |
|
161
SS&C Technologies
SSNC
$19.5B
| $2.44M | 0.08% |
69,019
-6,751
| -9% | -$227K |
|
162
Allison Transmission
ALSN
$11B
| $2.44M | 0.08% |
67,570
-4,486
| -6% | -$160K |
|
|
STOR
163
DELISTED
STORE Capital Corporation
STOR
| $2.44M | 0.08% |
102,042
+90,628
| +794% | +$2.2M |
|
164
IBM
IBM
$222B
| $2.4M | 0.07% |
14,417
+12,848
| +819% | +$2.15M |
|
165
Sarepta Therapeutics
SRPT
$1.98B
| $2.4M | 0.07% |
+80,929
| New | +$2.5M |
|
166
CSX Corp
CSX
$95.6B
| $2.36M | 0.07% |
151,968
-626,019
| -80% | -$9.54M |
|
167
Dollar Tree
DLTR
$25.3B
| $2.34M | 0.07% |
29,795
+17,702
| +146% | +$1.36M |
|
168
McKesson
MCK
$100B
| $2.33M | 0.07% |
15,721
-10,825
| -41% | -$1.59M |
|
169
Ralph Lauren
RL
$22.2B
| $2.31M | 0.07% |
28,356
+19,444
| +218% | +$1.6M |
|
170
Sinclair Inc
SBGI
$1.04B
| $2.3M | 0.07% |
56,806
+33,134
| +140% | +$1.22M |
|
171
PPG Industries
PPG
$25.3B
| $2.29M | 0.07% |
21,794
-11,856
| -35% | -$1.2M |
|
172
VeriSign
VRSN
$25.5B
| $2.29M | 0.07% |
26,282
+6,993
| +36% | +$581K |
|
173
Citigroup
C
$221B
| $2.26M | 0.07% |
37,777
+30,877
| +447% | +$1.83M |
|
174
TechnipFMC
FTI
$30.4B
| $2.25M | 0.07% |
93,068
+70,470
| +312% | +$1.74M |
|
|
ARD
175
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $2.22M | 0.07% |
+101,100
| New | +$2.22M |
|
Similar funds
Paul Tudor Jones's Q1 2017 Portfolio in Review
As of Q1 2017, Paul Tudor Jones held 1,687 positions worth $3.25B, down 16% from $3.88B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Paul Tudor Jones withdrew a net $793M in Q1 2017, closing 340 positions and reducing 514 holdings. Its most notable exit was St Jude Medical, an estimated $40.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Paul Tudor Jones opened a new position in iShares MSCI Emerging Markets ETF worth $72.8M.
- Paul Tudor Jones's largest Q1 2017 buy was iShares MSCI Emerging Markets ETF: 1,847,000 shares worth $72.8M.
- Paul Tudor Jones added most to Mead Johnson Nutrition Company in Q1 2017, an estimated $30.7M increase.
- Paul Tudor Jones's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $170M.
- Paul Tudor Jones fully exited St Jude Medical in Q1 2017, selling an estimated $40.7M.
- Paul Tudor Jones's ten largest holdings make up 31% of its $3.25B portfolio in Q1 2017.
- Paul Tudor Jones opened 332 new positions and closed 340 in Q1 2017.
- Paul Tudor Jones's portfolio value fell 16% quarter-over-quarter to $3.25B.
Based on Tudor Investment Corp's 13F filing for Q1 2017, filed 15 May 2017.